Boston: Capital events trigger significant leasing activity across clinical-stage life science firms
Almost every new lease or expansion can be attributed to a corresponding capital event
May 08, 2020
- We looked at every clinical-stage company lease transaction in Boston, Cambridge, Watertown, Lexington, and Waltham since the beginning of 2019. Nearly every transaction that occurred, was preceded by some form of capital event whether it be a VC Round, Licensing Agreement, or IPO. Often times that event occurred within 12-months of a lease being signed.
- 44 percent of the leases were preceded by VC/PE funding round, 25 percent were the result of a Licensing Agreement or Partnership, and 19 percent were from Initial Public Offerings.
- The median capital event raised $70 million for each company, which resulted in a median lease transaction of 42,000 square feet.